Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CEMIG Preferred Shares
CIG
$6.26B
| $13.2M | 0.01% |
8,878,464
-6,170,477
| -41% | -$8.67M |
|
1702
AXIS Capital
AXS
$7.68B
| $13.2M | 0.01% |
287,473
-60,428
| -17% | -$3M |
|
|
AONC
1703
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $13.2M | 0.01% |
1,363,722
+1,006,994
| +282% | +$9.76M |
|
1704
Pilgrim's Pride
PPC
$6.51B
| $13.2M | 0.01% |
454,853
-67,030
| -13% | -$1.68M |
|
1705
United Microelectronic
UMC
$47.7B
| $13.2M | 0.01% |
+1,153,343
| New | +$12.4M |
|
1706
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
| $13.2M | 0.01% |
506,008
-3,754,976
| -88% | -$93M |
|
1707
Edison International
EIX
$28.2B
| $13.2M | 0.01% |
237,434
+105,988
| +81% | +$6.08M |
|
1708
Copart
CPRT
$27B
| $13.1M | 0.01% |
378,676
+347,844
| +1,128% | +$12.4M |
|
1709
Las Vegas Sands
LVS
$31.7B
| $13.1M | 0.01% |
358,708
-1,258,344
| -78% | -$54M |
|
|
SLAM
1710
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $13.1M | 0.01% |
1,346,398
+546,168
| +68% | +$5.3M |
|
1711
WSFS Financial
WSFS
$4.12B
| $13.1M | 0.01% |
255,649
+237,309
| +1,294% | +$10.7M |
|
1712
Gildan
GIL
$10.3B
| $13.1M | 0.01% |
+358,074
| New | +$13.2M |
|
1713
PUT
Avantor
AVTR
$9.32B
| $13.1M | 0.01% |
319,800
+79,800
| +33% | +$3.12M |
|
|
FSRX
1714
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $13.1M | 0.01% |
1,341,997
+323,344
| +32% | +$3.14M |
|
1715
FTI Consulting
FCN
$4.4B
| $13M | 0.01% |
96,858
+27,184
| +39% | +$3.77M |
|
|
BSN
1716
DELISTED
Broadstone Acquisition Corp.
BSN
| $13M | 0.01% |
1,307,754
+142,403
| +12% | +$1.41M |
|
|
TCVA
1717
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $13M | 0.01% |
1,327,169
-5,904
| -0.4% | -$58.3K |
|
1718
STAG Industrial
STAG
$7.38B
| $13M | 0.01% |
331,336
-422,029
| -56% | -$17.2M |
|
|
HLGN
1719
DELISTED
Heliogen, Inc.
HLGN
| $13M | 0.01% |
37,366
+29,147
| +355% | +$10.1M |
|
1720
Amdocs
DOX
$5.92B
| $13M | 0.01% |
171,440
-33,361
| -16% | -$2.58M |
|
1721
Mercury Systems
MRCY
$5.83B
| $13M | 0.01% |
273,233
+34,362
| +14% | +$1.91M |
|
1722
UMB Financial
UMBF
$11.1B
| $13M | 0.01% |
133,961
+119,481
| +825% | +$10.9M |
|
1723
Ryman Hospitality Properties
RHP
$8.43B
| $12.9M | 0.01% |
154,705
-166,950
| -52% | -$13.3M |
|
1724
Manchester United
MANU
$3.97B
| $12.9M | 0.01% |
667,368
+574,017
| +615% | +$9.66M |
|
1725
Payoneer
PAYO
$2.42B
| $12.9M | 0.01% |
1,511,021
-6,383,333
| -81% | -$62M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.